Fluoroclebopride（Cat No.:M090914）is a fluorinated derivative of clebopride, functioning as a selective radioligand primarily used for imaging dopamine D₂/D₃ receptors via positron emission tomography (PET). With high affinity and specificity, Fluoroclebopride enables precise visualization and quantification of dopamine receptor distribution and occupancy in neurological studies. It significantly aids research into Parkinson’s disease, schizophrenia, and various psychiatric disorders by providing insights into dopaminergic dysfunction. Additionally, Fluoroclebopride’s robust pharmacokinetic profile facilitates accurate, non-invasive imaging, making it invaluable for assessing receptor dynamics, drug efficacy, and disease progression in clinical and preclinical neuroscience research.